NeuroPace, Inc.

NPCE Healthcare Medical Devices

In the quarter to June 2026, revenue grew 17.1%, EPS grew 30.8%, free cash flow fell 78.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

12.24 0.54 −4.23%
Market cap
$438.7M
P/E
0.0×
Fwd P/E
−27.1×
Dividend yield
—
F-score
5/9
Altman Z
−2.52
Beneish M
−2.88
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
95.33 94.07 86.98 86.19
Total non-current assets
11.93 11.49 11.92 10.80
Total Assets
107.26 105.57 98.90 96.99
Total current liabilities
19.61 17.81 16.17 17.43
Total non-current liabilities
69.13 68.72 68.28 67.68
Total liabilities
88.74 86.53 84.44 85.11
Common Equity (Total)
18.52 19.03 14.45 11.88
Shareholders Equity (Total)
18.52 19.03 14.45 11.88
Total Debt
58.75 58.88 59.02 59.01

Show all line items

In millions of $ except per-share values · columns are period end dates